A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy
Authors:
- 1 April 2005
- journal article
- clinical trial
- Published by Elsevier in Leukemia Research
- Vol. 29 (4) , 463-465
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Treatment of Impending Tumor Lysis with Single-Dose RasburicaseAnnals of Pharmacotherapy, 2003
- Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndromeLeukemia, 2003
- Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trialLeukemia, 2001